283 related articles for article (PubMed ID: 4032289)
21. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of oral desmopressin therapy in posterior urethral valve patients with polyuria and detection of factors affecting the therapy.
Naghizadeh S; Kefi A; Dogan HS; Burgu B; Akdogan B; Tekgul S
Eur Urol; 2005 Nov; 48(5):819-25. PubMed ID: 15998564
[TBL] [Abstract][Full Text] [Related]
23. Oral antidiuretic therapy: studies in the diabetes insipidus rat.
Kinter LB; Beeuwkes R
Am J Physiol; 1982 Nov; 243(5):R491-9. PubMed ID: 7137378
[TBL] [Abstract][Full Text] [Related]
24. Atrial natriuretic peptide secretion was not directly affected by arginine vasopressin in diabetes insipidus.
Shimizu H; Tanaka Y; Nakamura K; Uehara Y; Shimomura Y
J Med; 1991; 22(4-5):299-305. PubMed ID: 1838565
[TBL] [Abstract][Full Text] [Related]
25. DDAVP in the treatment of central diabetes insipidus.
Robinson AG
N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
[TBL] [Abstract][Full Text] [Related]
26. [Diabetes insipidus--with special reference to DDAVP therapy].
Shimizu K
Nihon Rinsho; 1979; 37(4):849-55. PubMed ID: 449070
[No Abstract] [Full Text] [Related]
27. [Treatment and effects of desmopressin (DDAVP) in patients with central diabetes insipidus (author's transl)].
Matsui K; Kimura T; Ota K; Iitake K; Yoshinaga K
Horumon To Rinsho; 1979 Aug; 27(8):891-5. PubMed ID: 487624
[No Abstract] [Full Text] [Related]
28. Prolonged antidiuresis by 1-desamino-8-D-arginine vasopressin (DDAVP): correlation to its plasma levels and nephrogenous cyclic AMP production.
Katayama S; Itabashi A; Yamaji T
Endocrinol Jpn; 1980 Jun; 27(3):363-70. PubMed ID: 6254752
[TBL] [Abstract][Full Text] [Related]
29. [The treatment of patients with diabetes insipidus by a synthetic analogue of vasopressin, DDAVP (author's transl)].
Tanae A; Shimizu K; Yoshida S
Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):676-91. PubMed ID: 689212
[TBL] [Abstract][Full Text] [Related]
30. Lack of elevation of urinary albumin excretion among patients with chronic syndromes of inappropriate antidiuresis.
Vandergheynst F; Decaux G
Nephrol Dial Transplant; 2008 Jul; 23(7):2399-401. PubMed ID: 18400823
[TBL] [Abstract][Full Text] [Related]
31. Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene.
Faerch M; Christensen JH; Corydon TJ; Kamperis K; de Zegher F; Gregersen N; Robertson GL; Rittig S
Clin Endocrinol (Oxf); 2008 Mar; 68(3):395-403. PubMed ID: 17941907
[TBL] [Abstract][Full Text] [Related]
32. Management of cranial diabetes insipidus with oral desmopressin (DDAVP).
Cunnah D; Ross G; Besser GM
Clin Endocrinol (Oxf); 1986 Mar; 24(3):253-7. PubMed ID: 3708875
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of ADP responsive diabetes insipidus in children with DDAVP (1-desamino-8-D-arginine-vasopressin)].
Limal JM; Mugner E; Czernichow P
Arch Fr Pediatr; 1977 Dec; 34(10):965-72. PubMed ID: 610662
[TBL] [Abstract][Full Text] [Related]
34. 1-deamino-/4-valine-8-D-arginine/-vasopressin (dVDAVP), a new synthetic vasopressin analog for treating diabetes insipidus.
László FA; Czakó L
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):39-43. PubMed ID: 7056603
[TBL] [Abstract][Full Text] [Related]
35. Individual differences in the antidiuretic response induced by single doses of 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
Radó JP; Marosi J; Borbély L; Takó J
Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):259-65. PubMed ID: 1002361
[TBL] [Abstract][Full Text] [Related]
36. The relationship between the action of arginine vasopressin and responsiveness to oral desmopressin in older men: a pilot study.
Johnson TM; Burridge A; Issa MM; Miller M; Tang T; Ouslander JG
J Am Geriatr Soc; 2007 Apr; 55(4):562-9. PubMed ID: 17397435
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
[TBL] [Abstract][Full Text] [Related]
38. Treatment of central diabetes insipidus in adults and children with desmopressin.
Ziai F; Walter R; Rosenthal IM
Arch Intern Med; 1978 Sep; 138(9):1382-5. PubMed ID: 686929
[TBL] [Abstract][Full Text] [Related]
39. Vasopressin analog DDAVP in the treatment of diabetes insipidus.
Lee WP; Lippe BM; La Franchi SH; Kaplan SA
Am J Dis Child; 1976 Feb; 130(2):166-9. PubMed ID: 766613
[TBL] [Abstract][Full Text] [Related]
40. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
Lebacq E; David L
Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
